Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to detect adverse drug reactions for long-term use (particularly
clinically significant adverse drug reactions) occurring in clinical settings, to examine
factors likely to affect the safety and efficacy in the Japanese asthma patients who are
treated with fluticasone propionate/salmeterol xinafoate.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate